Disease/Infection News

RSS

Quick, inexpensive leptospirosis test strip kit to help lower death and disability risk

The Faculty of Medicine, Chulalongkorn University has brought out a quick, inexpensive, and easy-to-use leptospirosis test strip kit to help lower the risk of disability from internal organ failure and death, with the hopes of distributing them to community hospitals across the country.

14 Aug 2021

World-first trial of third dose COVID-19 booster vaccine shows improved protection in transplant patients

Scientists with the Ajmera Transplant Centre at UHN have conducted a first-in-the-world randomized placebo-controlled trial of third dose COVID-19 booster vaccine for transplant patients that shows substantially improved protection.

14 Aug 2021

Study exposes the dire need for new clinical risk management tools to prevent COVID-19 deaths

A new study exposes the dire need for new clinical risk management tools to help hospital healthcare workers prevent the deaths and intensive care admissions of Black, Asian and minority ethnic (BAME) COVID-19 patients with pneumonia, say researchers.

13 Aug 2021

UC Davis joins with Pfizer for COVID-19 booster vaccine trial

As COVID-19 booster shots begin for those with compromised immune systems, researchers at the UC Davis School of Medicine continue to collect data from clinical trial participants.

13 Aug 2021

Emergency Department sees a significant increase in COVID-19 cases during August 2021

The Emergency Department (ED) at UC Davis Medical Center saw a 33% increase in COVID-19 patients during the first week of August, providing treatment for 107 patients, up from 80 patients the week before.

13 Aug 2021

Excess COVID-19 cases, deaths in the U.S. may be attributable to PM2.5 pollution from wildfires

Thousands of COVID-19 cases and deaths in California, Oregon, and Washington between March and December 2020 may be attributable to increases in fine particulate air pollution (PM2.5) from wildfire smoke, according to a new study co-authored by researchers at Harvard T.H. Chan School of Public Health.

13 Aug 2021

Scientists document person-to-person transmission of antimicrobial-resistant pneumonic plague

Although the world is focused on the COVID-19 pandemic, there are many other dangerous pathogens still out there, like Yersinia pestis, which causes plague – the deadly disease that killed tens of millions of people during the infamous Black Death in the 14th century.

13 Aug 2021

WHO outlines the next series of studies on the origins of SARS-CoV-2 virus

Since the start of the COVID-19 pandemic, WHO has been working with the Member States and the scientific community to better understand how this pandemic began so that we can be better prepared for the next one.

13 Aug 2021

Discovery of highly potent neutralizing monoclonal antibodies against SARS-CoV-2

A new study published in the journal Nature Communications has reported two neutralizing antibodies, namely, nCoVmab1 and nCoVmab2, which are potent against SARS-CoV-2.

13 Aug 2021

How replication and recombination contribute to emergence of SARS-CoV-2 variants

The coronavirus disease 2019 (COVID-19) pandemic has been caused by the rapid outbreak of a novel coronavirus, namely, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 was first reported in late December 2019 in Wuhan, China. Since then, the virus has already claimed more than 4.3 million lives worldwide.

13 Aug 2021

Research debunks myth that COVID vaccination promotes mutations

A study conducted by researchers at the University of Maryland, USA, has highlighted the importance of coronavirus disease 2019 (COVID-19) vaccination in reducing the frequency of mutations in the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

13 Aug 2021

SARS-CoV-2 variants containing L452R spike mutation more resistant to antibody-mediated neutralization

A team of scientists from Frankfurt, Germany, has recently explored the efficacy of vaccine- or infection-induced antibodies and therapeutic monoclonal antibodies in neutralizing kappa and delta variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

12 Aug 2021

Camelid nanobody anti-SARS-CoV-2 drug candidates

In a research paper recently published in the journal eLife, researchers from several US institutions have developed a nanobody-based candidate drug that effectively prevents and suppresses severe SARS-CoV-2 infection in animals.

12 Aug 2021

Optical nanoscopy reveals how SARS-CoV-2 infection alters human airway cells

How do viruses reorganize host cells with spatial and molecular specificity? Researchers from the Netherlands provided new insights in a recent study posted to the bioRxiv* preprint server, where they use optical nanoscopy to look at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-triggered changes in primary human airway cells.

12 Aug 2021

CDC's mask guidance may have increased the threat of COVID-19 among vulnerable communities

The Centers for Disease Control and Prevention may have increased the threat of COVID-19 infection in the Black community and among some other racial and ethnic minority groups when the agency updated its mask guidance last May, according to a new commentary in the Journal of General Internal Medicine by two colleagues at Massachusetts General Hospital.

12 Aug 2021

Researchers map the impact of Covid-19 on the mental well-being of Israelis

During the six weeks between the end of the first COVID-19 outbreak in Israel and the beginning of the second one (late April to early June of 2020), researchers at the Weizmann Institute of Science initiated a study that encompassed more than 12,000 responses from nearly 5,000 respondents to digital questionnaires, in an attempt to assess and understand the mental toll of the pandemic on the country's adult population.

12 Aug 2021

Researcher receives $8.7 million to investigate the link between viral infections and memory disorders

More than half of the survivors of West Nile virus brain infections are left with memory disorders that make everyday tasks such as remembering the route from home to work challenging.

12 Aug 2021

Study finds worsening disparities among states in use of HIV-prevention drugs

States with low initial use of HIV-prevention drugs are continuing to fall behind in usage among people at risk for the disease, a new study finds.

12 Aug 2021

South Australian-developed SARS-CoV-2 vaccine shows promise to prevent COVID-19 lung infection

A South Australian-developed SARS-CoV-19 vaccine is preparing to progress to the final stages of human clinical trials after early animal testing confirmed its safety and effectiveness in preventing COVID-19 lung infection.

12 Aug 2021

SARS-CoV-2 detection by machine learning surface-enhanced Raman spectroscopy

Surface-enhanced Raman spectroscopy is a highly sensitive molecule characterization method, significantly more sensitive than ordinary Raman spectroscopy due to the excitation of Raman modes matching the plasmon resonance frequency of the surface metal utilized, usually gold, silver, or copper.

11 Aug 2021

Disease/Infection News

Quick, inexpensive leptospirosis test strip kit to help lower death and disability risk

World-first trial of third dose COVID-19 booster vaccine shows improved protection in transplant patients

Study exposes the dire need for new clinical risk management tools to prevent COVID-19 deaths

UC Davis joins with Pfizer for COVID-19 booster vaccine trial

Emergency Department sees a significant increase in COVID-19 cases during August 2021

Excess COVID-19 cases, deaths in the U.S. may be attributable to PM2.5 pollution from wildfires

Scientists document person-to-person transmission of antimicrobial-resistant pneumonic plague

WHO outlines the next series of studies on the origins of SARS-CoV-2 virus

Discovery of highly potent neutralizing monoclonal antibodies against SARS-CoV-2

How replication and recombination contribute to emergence of SARS-CoV-2 variants

Research debunks myth that COVID vaccination promotes mutations

SARS-CoV-2 variants containing L452R spike mutation more resistant to antibody-mediated neutralization

Camelid nanobody anti-SARS-CoV-2 drug candidates

Optical nanoscopy reveals how SARS-CoV-2 infection alters human airway cells

CDC's mask guidance may have increased the threat of COVID-19 among vulnerable communities

Researchers map the impact of Covid-19 on the mental well-being of Israelis

Researcher receives $8.7 million to investigate the link between viral infections and memory disorders

Study finds worsening disparities among states in use of HIV-prevention drugs

South Australian-developed SARS-CoV-2 vaccine shows promise to prevent COVID-19 lung infection

SARS-CoV-2 detection by machine learning surface-enhanced Raman spectroscopy

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News